A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-07

AUTHORS

Priya Kumthekar, Sean Grimm, James Chandler, Minesh Mehta, Maryanne Marymont, Robert Levy, Kenji Muro, Irene Helenowski, Katie McCarthy, Leanne Fountas, Jeffrey Raizer

ABSTRACT

Standard treatment for GBM is radiation (RT) and temozolomide (TMZ). Arsenic trioxide (ATO) is synergistic with RT based on several mechanisms of action previously identified, however not tested herein. The MTD of ATO, RT and TMZ was determined in a Phase I trial. We now present the combined Phase I/II data. Patients with newly diagnosed malignant gliomas were eligible for treatment. Patients were treated with RT (60 GY), TMZ (75 mg/m2 daily × 42 days) and ATO 0.20 mg/kg daily in week 1 then twice a week ×5 weeks, after completing RT they were treated with TMZ 5/28 for up to 12 months. MRIs were performed every 8 weeks. A total of 42 patients were enrolled in both the Phase I and II trials for this study treatment. Of the 42 enrolled patients (24 M and 18 W) the median age was 54 (24-80) and median KPS 90 (60-100). 28 patients had a GBM and 14 had anaplastic glioma (AG). All patients completed RT/TMZ/ATO and went on to maintenance TMZ. Median number of post RT cycles of TMZ was 4 (0-12). Median PFS was 7 m for GBM and 75 m for AG and median OS was 17 m for GBM and NR for AG. Best response was CR in 2, SD in 28, PR in 5 and PD in 7. There were no unexpected adverse events. Grade 3 toxicities likely attributable to ATO included prolonged Qtc (n = 1), elevated liver enzymes (n = 2 for ALT/n = 1 for AST) and elevated bilirubin (n = 1). Adding ATO to RT and TMZ is feasible with no increased side effects. The addition of arsenic did not improve overall survival in the GBM patients as compared to historic data. MGMT status was analyzed in 20 of the 42 patients where tissue was available for retrieval and MGMT testing. More... »

PAGES

589-594

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11060-017-2469-x

DOI

http://dx.doi.org/10.1007/s11060-017-2469-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1085422047

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28510787


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Alkylating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arsenic Trioxide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arsenicals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemoradiotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dacarbazine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Magnetic Resonance Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Temozolomide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Northwestern Medicine", 
          "id": "https://www.grid.ac/institutes/grid.490348.2", 
          "name": [
            "Department of Neurology, Northwestern Medicine, 710 North Lake Shore Dr., Abbott Hall Room 1122, 60611, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kumthekar", 
        "givenName": "Priya", 
        "id": "sg:person.01272413370.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272413370.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northwestern Medicine", 
          "id": "https://www.grid.ac/institutes/grid.490348.2", 
          "name": [
            "Department of Neurology, Northwestern Medicine, 710 North Lake Shore Dr., Abbott Hall Room 1122, 60611, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grimm", 
        "givenName": "Sean", 
        "id": "sg:person.0576221411.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576221411.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northwestern Medicine", 
          "id": "https://www.grid.ac/institutes/grid.490348.2", 
          "name": [
            "Department of Neurosurgery, Northwestern Medicine, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chandler", 
        "givenName": "James", 
        "id": "sg:person.01336541541.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336541541.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Baptist Health South Florida", 
          "id": "https://www.grid.ac/institutes/grid.418212.c", 
          "name": [
            "Miami Cancer Institute, Miami, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mehta", 
        "givenName": "Minesh", 
        "id": "sg:person.01063171335.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063171335.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northwestern Medicine", 
          "id": "https://www.grid.ac/institutes/grid.490348.2", 
          "name": [
            "Department of Neurology, Northwestern Medicine, 710 North Lake Shore Dr., Abbott Hall Room 1122, 60611, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marymont", 
        "givenName": "Maryanne", 
        "id": "sg:person.01120107461.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01120107461.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Neurosurgery, Jacksonville, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Levy", 
        "givenName": "Robert", 
        "id": "sg:person.016200013707.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016200013707.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Advocate Health Department of Neurosurgery, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Muro", 
        "givenName": "Kenji", 
        "id": "sg:person.01107142355.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107142355.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northwestern University", 
          "id": "https://www.grid.ac/institutes/grid.16753.36", 
          "name": [
            "Department of Biostatistics, Northwestern University, Evanston, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Helenowski", 
        "givenName": "Irene", 
        "id": "sg:person.01125347407.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125347407.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northwestern Medicine", 
          "id": "https://www.grid.ac/institutes/grid.490348.2", 
          "name": [
            "Northwestern Medicine Cancer Research Office, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McCarthy", 
        "givenName": "Katie", 
        "id": "sg:person.01276254470.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276254470.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northwestern Medicine", 
          "id": "https://www.grid.ac/institutes/grid.490348.2", 
          "name": [
            "Northwestern Medicine Cancer Research Office, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fountas", 
        "givenName": "Leanne", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northwestern Medicine", 
          "id": "https://www.grid.ac/institutes/grid.490348.2", 
          "name": [
            "Department of Neurology, Northwestern Medicine, 710 North Lake Shore Dr., Abbott Hall Room 1122, 60611, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raizer", 
        "givenName": "Jeffrey", 
        "id": "sg:person.010677556177.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010677556177.51"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11060-014-1520-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000198245", 
          "https://doi.org/10.1007/s11060-014-1520-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-010-0406-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001363291", 
          "https://doi.org/10.1007/s11060-010-0406-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(09)70025-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002463620"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/nos218", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006436675"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2004.02.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007477247"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.canlet.2009.11.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011862562"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2005.12.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019109104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.1217602110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034779025"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.5836", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034950655"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1756-8722-3-28", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041035664", 
          "https://doi.org/10.1186/1756-8722-3-28"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5483/bmbrep.2011.44.3.158", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046424423"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-015-1771-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048017416", 
          "https://doi.org/10.1007/s11060-015-1771-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-010-0582-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050115752", 
          "https://doi.org/10.1007/s12185-010-0582-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-010-0582-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050115752", 
          "https://doi.org/10.1007/s12185-010-0582-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-012-0957-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052864724", 
          "https://doi.org/10.1007/s11060-012-0957-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmc1403303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053537164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/now133", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059935256"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/cc.24747", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072297172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075087927", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1990.8.7.1277", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078716995"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-07", 
    "datePublishedReg": "2017-07-01", 
    "description": "Standard treatment for GBM is radiation (RT) and temozolomide (TMZ). Arsenic trioxide (ATO) is synergistic with RT based on several mechanisms of action previously identified, however not tested herein. The MTD of ATO, RT and TMZ was determined in a Phase I trial. We now present the combined Phase I/II data. Patients with newly diagnosed malignant gliomas were eligible for treatment. Patients were treated with RT (60 GY), TMZ (75\u00a0mg/m2 daily\u2009\u00d7\u200942 days) and ATO 0.20\u00a0mg/kg daily in week 1 then twice a week \u00d75 weeks, after completing RT they were treated with TMZ 5/28 for up to 12 months. MRIs were performed every 8 weeks. A total of 42 patients were enrolled in both the Phase I and II trials for this study treatment. Of the 42 enrolled patients (24\u00a0M and 18\u00a0W) the median age was 54 (24-80) and median KPS 90 (60-100). 28 patients had a GBM and 14 had anaplastic glioma (AG). All patients completed RT/TMZ/ATO and went on to maintenance TMZ. Median number of post RT cycles of TMZ was 4 (0-12). Median PFS was 7\u00a0m for GBM and 75\u00a0m for AG and median OS was 17\u00a0m for GBM and NR for AG. Best response was CR in 2, SD in 28, PR in 5 and PD in 7. There were no unexpected adverse events. Grade 3 toxicities likely attributable to ATO included prolonged Qtc (n\u2009=\u20091), elevated liver enzymes (n\u2009=\u20092 for ALT/n\u00a0=\u20091 for AST) and elevated bilirubin (n\u2009=\u20091). Adding ATO to RT and TMZ is feasible with no increased side effects. The addition of arsenic did not improve overall survival in the GBM patients as compared to historic data. MGMT status was analyzed in 20 of the 42 patients where tissue was available for retrieval and MGMT testing.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11060-017-2469-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094205", 
        "issn": [
          "0167-594X", 
          "1573-7373"
        ], 
        "name": "Journal of Neuro-Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "133"
      }
    ], 
    "name": "A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas", 
    "pagination": "589-594", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "3a6f3aa92859ec500da9e7506c1b168c460b832046a6fbca1c2dbd08dbfe740e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28510787"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309335"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11060-017-2469-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1085422047"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11060-017-2469-x", 
      "https://app.dimensions.ai/details/publication/pub.1085422047"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89826_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs11060-017-2469-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-017-2469-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-017-2469-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-017-2469-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-017-2469-x'


 

This table displays all metadata directly associated to this object as RDF triples.

296 TRIPLES      21 PREDICATES      69 URIs      42 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11060-017-2469-x schema:about N0400bf7600b04dca9a8245a99c198ae3
2 N078242a120ca49fa9d4e7320d4e191ba
3 N13d59149ef234202bd61848e7771ba31
4 N265592464cfe4e2aae03b49673a07c98
5 N4041699c5db9478d9dbe6036e16ac336
6 N4c99974846654e959913d396693749da
7 N4f37de1147984552bdc53a08f7dbc7b8
8 N6997f22c7344425fbf6c62464be709d1
9 N7cea30146fa448e2a6aeada55064eb9c
10 N82d1251812044a52a4f6d65149dda9c6
11 N9afb0e5653f345039e0778331773e661
12 Na315de2d443446cfae65bbaafde3a51b
13 Nbf80b4ed28764f5d942a882afcc4dbfc
14 Nc7f319c2454f42bbb33de285119bf209
15 Nce17b52e70cc410ab1e4f58201e49170
16 Nd618ee31d87441349977605db8259122
17 Nd8eafb694db5476cb2aba477d5efb1b6
18 Nd8f57da9ef8f47e889be965527f3d0b5
19 Nda10422ba277465dbdda42e0aefe4bfe
20 Ndc7156b3270946ab85f9a8591a5910bf
21 Necaa85b3cfcc48019fe27acb8cbc0d6d
22 anzsrc-for:11
23 anzsrc-for:1103
24 schema:author Nad7ab162759949929e1791ddfbec04db
25 schema:citation sg:pub.10.1007/s11060-010-0406-3
26 sg:pub.10.1007/s11060-012-0957-6
27 sg:pub.10.1007/s11060-014-1520-4
28 sg:pub.10.1007/s11060-015-1771-8
29 sg:pub.10.1007/s12185-010-0582-0
30 sg:pub.10.1186/1756-8722-3-28
31 https://app.dimensions.ai/details/publication/pub.1075087927
32 https://doi.org/10.1016/j.canlet.2009.11.005
33 https://doi.org/10.1016/j.ijrobp.2004.02.013
34 https://doi.org/10.1016/j.ijrobp.2005.12.015
35 https://doi.org/10.1016/s1470-2045(09)70025-7
36 https://doi.org/10.1056/nejmc1403303
37 https://doi.org/10.1073/pnas.1217602110
38 https://doi.org/10.1093/neuonc/nos218
39 https://doi.org/10.1093/neuonc/now133
40 https://doi.org/10.1200/jco.1990.8.7.1277
41 https://doi.org/10.18632/oncotarget.5836
42 https://doi.org/10.4161/cc.24747
43 https://doi.org/10.5483/bmbrep.2011.44.3.158
44 schema:datePublished 2017-07
45 schema:datePublishedReg 2017-07-01
46 schema:description Standard treatment for GBM is radiation (RT) and temozolomide (TMZ). Arsenic trioxide (ATO) is synergistic with RT based on several mechanisms of action previously identified, however not tested herein. The MTD of ATO, RT and TMZ was determined in a Phase I trial. We now present the combined Phase I/II data. Patients with newly diagnosed malignant gliomas were eligible for treatment. Patients were treated with RT (60 GY), TMZ (75 mg/m<sup>2</sup> daily × 42 days) and ATO 0.20 mg/kg daily in week 1 then twice a week ×5 weeks, after completing RT they were treated with TMZ 5/28 for up to 12 months. MRIs were performed every 8 weeks. A total of 42 patients were enrolled in both the Phase I and II trials for this study treatment. Of the 42 enrolled patients (24 M and 18 W) the median age was 54 (24-80) and median KPS 90 (60-100). 28 patients had a GBM and 14 had anaplastic glioma (AG). All patients completed RT/TMZ/ATO and went on to maintenance TMZ. Median number of post RT cycles of TMZ was 4 (0-12). Median PFS was 7 m for GBM and 75 m for AG and median OS was 17 m for GBM and NR for AG. Best response was CR in 2, SD in 28, PR in 5 and PD in 7. There were no unexpected adverse events. Grade 3 toxicities likely attributable to ATO included prolonged Qtc (n = 1), elevated liver enzymes (n = 2 for ALT/n = 1 for AST) and elevated bilirubin (n = 1). Adding ATO to RT and TMZ is feasible with no increased side effects. The addition of arsenic did not improve overall survival in the GBM patients as compared to historic data. MGMT status was analyzed in 20 of the 42 patients where tissue was available for retrieval and MGMT testing.
47 schema:genre research_article
48 schema:inLanguage en
49 schema:isAccessibleForFree false
50 schema:isPartOf Ndbdd154737634f17802dcfbc8a4d8843
51 Nf21a86759ef4465699a51557980fcfdf
52 sg:journal.1094205
53 schema:name A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas
54 schema:pagination 589-594
55 schema:productId N5ffd25fc6fdf4807b31c1412f2b414e1
56 N79a2dfbf5eb744ec85c293c7bf912b7b
57 Nb75a7992511b401fb3469efbbe4b3670
58 Nbf8deed020974bc08662e5c529e2923b
59 Nf291c2b2b2ea4b048cd11abbb5c4b14d
60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085422047
61 https://doi.org/10.1007/s11060-017-2469-x
62 schema:sdDatePublished 2019-04-11T10:04
63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
64 schema:sdPublisher N9369656f85cd47b79a23a28b302b6124
65 schema:url https://link.springer.com/10.1007%2Fs11060-017-2469-x
66 sgo:license sg:explorer/license/
67 sgo:sdDataset articles
68 rdf:type schema:ScholarlyArticle
69 N0400bf7600b04dca9a8245a99c198ae3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Drug Therapy, Combination
71 rdf:type schema:DefinedTerm
72 N078242a120ca49fa9d4e7320d4e191ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Aged
74 rdf:type schema:DefinedTerm
75 N13d59149ef234202bd61848e7771ba31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Female
77 rdf:type schema:DefinedTerm
78 N1ac2cc5bf57f47d38995403b49cfa157 rdf:first sg:person.01063171335.42
79 rdf:rest Na47d43d030ea4f7ab104cf532e90e301
80 N25c1e6ef97a74bc5bccc8d0a993dea84 rdf:first sg:person.016200013707.26
81 rdf:rest Ncf71706772f54892ab5248cb1248823c
82 N265592464cfe4e2aae03b49673a07c98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Arsenic Trioxide
84 rdf:type schema:DefinedTerm
85 N362bda4ee5b94ce0860a661197eecedd rdf:first Nf00df97f16eb4fafa62e5db52bf2e74d
86 rdf:rest N86b6324fcd3342f0923ae3fea2c5364a
87 N4041699c5db9478d9dbe6036e16ac336 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Arsenicals
89 rdf:type schema:DefinedTerm
90 N425f9346c334452290777f685df30684 rdf:first sg:person.01125347407.01
91 rdf:rest N98a873dbd6834d36b5df567e5d63db93
92 N48aa0e7d0d3d48debb04bcf867225ea4 schema:name Department of Neurosurgery, Jacksonville, FL, USA
93 rdf:type schema:Organization
94 N4c99974846654e959913d396693749da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Kaplan-Meier Estimate
96 rdf:type schema:DefinedTerm
97 N4f37de1147984552bdc53a08f7dbc7b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Middle Aged
99 rdf:type schema:DefinedTerm
100 N5ffd25fc6fdf4807b31c1412f2b414e1 schema:name readcube_id
101 schema:value 3a6f3aa92859ec500da9e7506c1b168c460b832046a6fbca1c2dbd08dbfe740e
102 rdf:type schema:PropertyValue
103 N6997f22c7344425fbf6c62464be709d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Glioma
105 rdf:type schema:DefinedTerm
106 N6b412a2eb313436abd64539b3c30db3c schema:name Advocate Health Department of Neurosurgery, Chicago, IL, USA
107 rdf:type schema:Organization
108 N79a2dfbf5eb744ec85c293c7bf912b7b schema:name nlm_unique_id
109 schema:value 8309335
110 rdf:type schema:PropertyValue
111 N7cea30146fa448e2a6aeada55064eb9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Male
113 rdf:type schema:DefinedTerm
114 N82d1251812044a52a4f6d65149dda9c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Oxides
116 rdf:type schema:DefinedTerm
117 N86b6324fcd3342f0923ae3fea2c5364a rdf:first sg:person.010677556177.51
118 rdf:rest rdf:nil
119 N9369656f85cd47b79a23a28b302b6124 schema:name Springer Nature - SN SciGraph project
120 rdf:type schema:Organization
121 N98a873dbd6834d36b5df567e5d63db93 rdf:first sg:person.01276254470.76
122 rdf:rest N362bda4ee5b94ce0860a661197eecedd
123 N9afb0e5653f345039e0778331773e661 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Magnetic Resonance Imaging
125 rdf:type schema:DefinedTerm
126 Na315de2d443446cfae65bbaafde3a51b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Brain Neoplasms
128 rdf:type schema:DefinedTerm
129 Na47d43d030ea4f7ab104cf532e90e301 rdf:first sg:person.01120107461.82
130 rdf:rest N25c1e6ef97a74bc5bccc8d0a993dea84
131 Nad7ab162759949929e1791ddfbec04db rdf:first sg:person.01272413370.53
132 rdf:rest Nb80949a14e994365baabb4ea7cb358ff
133 Nb75a7992511b401fb3469efbbe4b3670 schema:name doi
134 schema:value 10.1007/s11060-017-2469-x
135 rdf:type schema:PropertyValue
136 Nb80949a14e994365baabb4ea7cb358ff rdf:first sg:person.0576221411.84
137 rdf:rest Nbc675ab14fa044a7bf27755a0ca81344
138 Nbc675ab14fa044a7bf27755a0ca81344 rdf:first sg:person.01336541541.17
139 rdf:rest N1ac2cc5bf57f47d38995403b49cfa157
140 Nbf80b4ed28764f5d942a882afcc4dbfc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Antineoplastic Agents, Alkylating
142 rdf:type schema:DefinedTerm
143 Nbf8deed020974bc08662e5c529e2923b schema:name pubmed_id
144 schema:value 28510787
145 rdf:type schema:PropertyValue
146 Nc7f319c2454f42bbb33de285119bf209 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Dacarbazine
148 rdf:type schema:DefinedTerm
149 Nce17b52e70cc410ab1e4f58201e49170 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Young Adult
151 rdf:type schema:DefinedTerm
152 Ncf71706772f54892ab5248cb1248823c rdf:first sg:person.01107142355.21
153 rdf:rest N425f9346c334452290777f685df30684
154 Nd618ee31d87441349977605db8259122 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Treatment Outcome
156 rdf:type schema:DefinedTerm
157 Nd8eafb694db5476cb2aba477d5efb1b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Adult
159 rdf:type schema:DefinedTerm
160 Nd8f57da9ef8f47e889be965527f3d0b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Temozolomide
162 rdf:type schema:DefinedTerm
163 Nda10422ba277465dbdda42e0aefe4bfe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Chemoradiotherapy
165 rdf:type schema:DefinedTerm
166 Ndbdd154737634f17802dcfbc8a4d8843 schema:volumeNumber 133
167 rdf:type schema:PublicationVolume
168 Ndc7156b3270946ab85f9a8591a5910bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Aged, 80 and over
170 rdf:type schema:DefinedTerm
171 Necaa85b3cfcc48019fe27acb8cbc0d6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Humans
173 rdf:type schema:DefinedTerm
174 Nf00df97f16eb4fafa62e5db52bf2e74d schema:affiliation https://www.grid.ac/institutes/grid.490348.2
175 schema:familyName Fountas
176 schema:givenName Leanne
177 rdf:type schema:Person
178 Nf21a86759ef4465699a51557980fcfdf schema:issueNumber 3
179 rdf:type schema:PublicationIssue
180 Nf291c2b2b2ea4b048cd11abbb5c4b14d schema:name dimensions_id
181 schema:value pub.1085422047
182 rdf:type schema:PropertyValue
183 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
184 schema:name Medical and Health Sciences
185 rdf:type schema:DefinedTerm
186 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
187 schema:name Clinical Sciences
188 rdf:type schema:DefinedTerm
189 sg:journal.1094205 schema:issn 0167-594X
190 1573-7373
191 schema:name Journal of Neuro-Oncology
192 rdf:type schema:Periodical
193 sg:person.01063171335.42 schema:affiliation https://www.grid.ac/institutes/grid.418212.c
194 schema:familyName Mehta
195 schema:givenName Minesh
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063171335.42
197 rdf:type schema:Person
198 sg:person.010677556177.51 schema:affiliation https://www.grid.ac/institutes/grid.490348.2
199 schema:familyName Raizer
200 schema:givenName Jeffrey
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010677556177.51
202 rdf:type schema:Person
203 sg:person.01107142355.21 schema:affiliation N6b412a2eb313436abd64539b3c30db3c
204 schema:familyName Muro
205 schema:givenName Kenji
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107142355.21
207 rdf:type schema:Person
208 sg:person.01120107461.82 schema:affiliation https://www.grid.ac/institutes/grid.490348.2
209 schema:familyName Marymont
210 schema:givenName Maryanne
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01120107461.82
212 rdf:type schema:Person
213 sg:person.01125347407.01 schema:affiliation https://www.grid.ac/institutes/grid.16753.36
214 schema:familyName Helenowski
215 schema:givenName Irene
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125347407.01
217 rdf:type schema:Person
218 sg:person.01272413370.53 schema:affiliation https://www.grid.ac/institutes/grid.490348.2
219 schema:familyName Kumthekar
220 schema:givenName Priya
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272413370.53
222 rdf:type schema:Person
223 sg:person.01276254470.76 schema:affiliation https://www.grid.ac/institutes/grid.490348.2
224 schema:familyName McCarthy
225 schema:givenName Katie
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276254470.76
227 rdf:type schema:Person
228 sg:person.01336541541.17 schema:affiliation https://www.grid.ac/institutes/grid.490348.2
229 schema:familyName Chandler
230 schema:givenName James
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336541541.17
232 rdf:type schema:Person
233 sg:person.016200013707.26 schema:affiliation N48aa0e7d0d3d48debb04bcf867225ea4
234 schema:familyName Levy
235 schema:givenName Robert
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016200013707.26
237 rdf:type schema:Person
238 sg:person.0576221411.84 schema:affiliation https://www.grid.ac/institutes/grid.490348.2
239 schema:familyName Grimm
240 schema:givenName Sean
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576221411.84
242 rdf:type schema:Person
243 sg:pub.10.1007/s11060-010-0406-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001363291
244 https://doi.org/10.1007/s11060-010-0406-3
245 rdf:type schema:CreativeWork
246 sg:pub.10.1007/s11060-012-0957-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052864724
247 https://doi.org/10.1007/s11060-012-0957-6
248 rdf:type schema:CreativeWork
249 sg:pub.10.1007/s11060-014-1520-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000198245
250 https://doi.org/10.1007/s11060-014-1520-4
251 rdf:type schema:CreativeWork
252 sg:pub.10.1007/s11060-015-1771-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048017416
253 https://doi.org/10.1007/s11060-015-1771-8
254 rdf:type schema:CreativeWork
255 sg:pub.10.1007/s12185-010-0582-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050115752
256 https://doi.org/10.1007/s12185-010-0582-0
257 rdf:type schema:CreativeWork
258 sg:pub.10.1186/1756-8722-3-28 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041035664
259 https://doi.org/10.1186/1756-8722-3-28
260 rdf:type schema:CreativeWork
261 https://app.dimensions.ai/details/publication/pub.1075087927 schema:CreativeWork
262 https://doi.org/10.1016/j.canlet.2009.11.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011862562
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1016/j.ijrobp.2004.02.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007477247
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1016/j.ijrobp.2005.12.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019109104
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1016/s1470-2045(09)70025-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002463620
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1056/nejmc1403303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053537164
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1073/pnas.1217602110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034779025
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1093/neuonc/nos218 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006436675
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1093/neuonc/now133 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059935256
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1200/jco.1990.8.7.1277 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078716995
279 rdf:type schema:CreativeWork
280 https://doi.org/10.18632/oncotarget.5836 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034950655
281 rdf:type schema:CreativeWork
282 https://doi.org/10.4161/cc.24747 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072297172
283 rdf:type schema:CreativeWork
284 https://doi.org/10.5483/bmbrep.2011.44.3.158 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046424423
285 rdf:type schema:CreativeWork
286 https://www.grid.ac/institutes/grid.16753.36 schema:alternateName Northwestern University
287 schema:name Department of Biostatistics, Northwestern University, Evanston, IL, USA
288 rdf:type schema:Organization
289 https://www.grid.ac/institutes/grid.418212.c schema:alternateName Baptist Health South Florida
290 schema:name Miami Cancer Institute, Miami, FL, USA
291 rdf:type schema:Organization
292 https://www.grid.ac/institutes/grid.490348.2 schema:alternateName Northwestern Medicine
293 schema:name Department of Neurology, Northwestern Medicine, 710 North Lake Shore Dr., Abbott Hall Room 1122, 60611, Chicago, IL, USA
294 Department of Neurosurgery, Northwestern Medicine, Chicago, IL, USA
295 Northwestern Medicine Cancer Research Office, Chicago, IL, USA
296 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...